K S Cadenhead
Overview
Explore the profile of K S Cadenhead including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
819
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kennedy L, Ku B, Addington J, Amir C, Bearden C, Cannon T, et al.
Schizophr Res
. 2024 Jul;
271:319-331.
PMID: 39084107
Background: Neurocognitive deficits have been widely reported in clinical high-risk for psychosis (CHR) populations. Additionally, rates of cannabis use are high among CHR youth and are associated with greater symptom...
2.
Dixon T, Cadenhead K
Trials
. 2023 Dec;
24(1):775.
PMID: 38037108
Background: Psychotic disorders are a leading cause of disability in young adults. Antipsychotics have been the primary intervention for psychosis for over 60 years, and yet, we have made little...
3.
Devoe D, Cadenhead K, Cornblatt B, Granholm E, Addington J
Behav Cogn Psychother
. 2021 Nov;
:1-14.
PMID: 34784991
Background: Investigations into possible mechanisms that may contribute to the development, maintenance, and exacerbation of negative symptoms are needed. Defeatist beliefs, self-efficacy, and early maladaptive schemas have been shown to...
4.
Devoe D, Lu L, Cannon T, Cadenhead K, Cornblatt B, McGlashan T, et al.
Schizophr Res
. 2020 May;
227:28-37.
PMID: 32362460
Background: Severity of negative symptoms has been associated with poor functioning, cognitive deficits, and defeatist beliefs in schizophrenia patients. However, one area that remains understudied is persistent negative symptoms (PNS)....
5.
Velikonja T, Velthorst E, Zinberg J, Cannon T, Cornblatt B, Perkins D, et al.
Dev Psychopathol
. 2020 Jan;
33(1):53-64.
PMID: 31959269
Evidence suggests that early trauma may have a negative effect on cognitive functioning in individuals with psychosis, yet the relationship between childhood trauma and cognition among those at clinical high...
6.
Brodey B, Girgis R, Favorov O, Bearden C, Woods S, Addington J, et al.
Schizophr Res
. 2019 Feb;
208:390-396.
PMID: 30777603
Introduction: A faster and more accurate self-report screener for early psychosis is needed to promote early identification and intervention. Methods: Self-report Likert-scale survey items were administered to individuals being screened...
7.
Shakeel M, Lu L, Cannon T, Cadenhead K, Cornblatt B, McGlashan T, et al.
Schizophr Res
. 2018 Sep;
204:334-336.
PMID: 30181061
Social cognition deficits have been observed in individuals at clinical high risk (CHR) for psychosis. Longitudinal change in social cognition were analyzed in CHR individuals from the North American Prodrome...
8.
Jeffries C, Perkins D, Chandler S, Stark T, Yeo E, Addington J, et al.
Transl Psychiatry
. 2016 Dec;
6(12):e981.
PMID: 27959328
Dysregulation of immune system functions has been implicated in schizophrenia, suggesting that immune cells may be involved in the development of the disorder. With the goal of a biomarker assay...
9.
Buchy L, Cadenhead K, Cannon T, Cornblatt B, McGlashan T, Perkins D, et al.
Psychol Med
. 2015 Mar;
45(11):2275-84.
PMID: 25727300
Background: A series of research reports has indicated that the use of substances such as cannabis, alcohol and tobacco are higher in youth at clinical high risk (CHR) of developing...
10.
Auther A, Cadenhead K, Carrion R, Addington J, Bearden C, Cannon T, et al.
Acta Psychiatr Scand
. 2015 Jan;
132(1):60-8.
PMID: 25572323
Objective: Cannabis use has been examined as a predictor of psychosis in clinical high-risk (CHR) samples, but little is known about the impact of other substances on this relationship. Method:...